Tarveda Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-02. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Biotechnology.
Showing 25 of 46 people.
| Name | Role | Location |
|---|---|---|
| James S Barrett | Director | Waltham, MA |
| David S Berry | Director | Waltham, MA |
| Omid Farokhzad | Director | Boston, MA |
| Shadi Barton Aryanpour | Executive Officer | Waltham, MA |
| Jeffrey Barton Quillen | Executive Officer | Waltham, MA |
| James Barrett | Director | Richmond, VA |
| Dennis Ausiello | Director | San Jose, CA |
| Andrew Fromkin | Director | New York, NY |
| Andrew Fromkin | Executive Officer | New York, NY |
| Aymeric Sallin | Director | Santa Clara, CA |
| Aymeric S Sallin | Director | Gaithersburg, MD |
| Peter Barton Hutt | Director | Salt Lake City, UT |
| Brian Roberts | Director | New York, NY |
| Brian Roberts | Executive Officer | New York, NY |
| Michael Metzger | Director | Watertown, MA |
| Nilesh Kumar | Director | Watertown, MA |
| Guido Magni | Director | Watertown, MA |
| Robert J Langer | Director | Woburn, MA |
| Aymeric J Sallin | Director | Watertown, MA |
| Nilesh J Kumar | Director | Watertown, MA |
| Guido J Magni | Director | Watertown, MA |
| Omid J Farokhzad | Director | Watertown, MA |
| Andrew J Fromkin | Director | Watertown, MA |
| Andrew J Fromkin | Executive Officer | Watertown, MA |
| Robert S Langer | Director | Newton, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-09-27 | D | $6.0M | $6.0M |
| 2020-12-28 | D | $15.4M | $15.0M |
| 2019-12-26 | D | $13.6M | $13.6M |
| 2017-02-09 | D | $30.0M | $30.0M |
| 2017-02-09 | D/A | $38.0M | $38.0M |
| 2016-01-29 | D | $38.0M | $25.5M |
| 2014-03-12 | D | $1000K | $1000K |
| 2013-12-24 | D/A | $21.0M | $21.0M |
| 2012-12-20 | D | $21.0M | $16.0M |